Work

Safety Reporting for Auxiliary Medicinal Products in the SibeprenlimabPhase-III Study According to the New European Union (536/2014) CTRegulation

Year: 2025

Type: article

Source: Current Drug Safety

DOI: 10.2174/0115748863329287250411114336

Authors: Retesh Kumar, Pratyush Giri, Mai Huang, Nipa Parikh, Vikalp Khare, Catherine Sheppard, Vinu George

Institutions: Otsuka (United Kingdom), Otsuka (United States), Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409987302

FWCI:

Cites:

Cited by:

Related to: 10